Slawomir Wawrzyniak

Bydgoszcz, KP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Recommendations of Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society and the Polish Society of Gynecologists and Obstetricians for family planning and pregnancy management in women with multiple sclerosis: an update.

Recommendations of Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society and the Polish Society of Gynecologists and Obstetricians for family planning and pregnancy management in women with multiple sclerosis: an update.

Journal: Neurologia i neurochirurgia polska

Published: March 08, 2026

Revised recommendations of the Polish Medical Society of Radiology and the Polish Neurological Society for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis.

Revised recommendations of the Polish Medical Society of Radiology and the Polish Neurological Society for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis.

Journal: Neurologia i neurochirurgia polska

Published: March 05, 2026

Evaluation of Selected Serum Adipocytokines in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Immunomodulatory Second-Line Drugs.

Evaluation of Selected Serum Adipocytokines in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Immunomodulatory Second-Line Drugs.

Journal: International journal of molecular sciences

Published: June 26, 2025

Herpes zoster prevention in multiple sclerosis and neuromyelitis optica spectrum disorders.

Herpes zoster prevention in multiple sclerosis and neuromyelitis optica spectrum disorders.

Journal: Neurologia i neurochirurgia polska

Published: October 10, 2024

Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society.

Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society.

Journal: Neurologia i neurochirurgia polska

Published: August 30, 2024

Recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society and Immuno-oncology Section of Polish Society of Oncology on oncological risk in patients with multiple sclerosis undergoing immunomodulatory therapy.

Recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society and Immuno-oncology Section of Polish Society of Oncology on oncological risk in patients with multiple sclerosis undergoing immunomodulatory therapy.

Journal: Neurologia i neurochirurgia polska

Published: August 09, 2024

Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society.

Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society.

Journal: Neurologia i neurochirurgia polska

Published: May 31, 2024

Multiple sclerosis and autoimmune diseases - a case control study.

Multiple sclerosis and autoimmune diseases - a case control study.

Journal: Neurologia i neurochirurgia polska

Published: November 22, 2022

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland.

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland.

Journal: Journal of clinical medicine

Published: September 15, 2021

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.

Journal: Journal of clinical medicine

Published: March 03, 2021

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.

Journal: Neurologia i neurochirurgia polska

Published: February 24, 2021

Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19?

Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19?

Journal: Neurologia i neurochirurgia polska

Published: August 12, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026